Les Sulewski
Stock Analyst at Truist Securities
(1.08)
# 3,820
Out of 5,055 analysts
14
Total ratings
53.85%
Success rate
-16.53%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Les Sulewski
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PCRX Pacira BioSciences | Maintains: Buy | $30 → $28 | $23.78 | +17.75% | 7 | Nov 7, 2025 | |
| COLL Collegium Pharmaceutical | Maintains: Buy | $45 → $48 | $46.01 | +4.33% | 3 | Nov 7, 2025 | |
| TEVA Teva Pharmaceutical Industries | Initiates: Buy | $25 | $25.41 | -1.61% | 1 | May 28, 2025 | |
| AMRX Amneal Pharmaceuticals | Maintains: Buy | $10 → $12 | $11.64 | +3.09% | 3 | Oct 2, 2024 |
Pacira BioSciences
Nov 7, 2025
Maintains: Buy
Price Target: $30 → $28
Current: $23.78
Upside: +17.75%
Collegium Pharmaceutical
Nov 7, 2025
Maintains: Buy
Price Target: $45 → $48
Current: $46.01
Upside: +4.33%
Teva Pharmaceutical Industries
May 28, 2025
Initiates: Buy
Price Target: $25
Current: $25.41
Upside: -1.61%
Amneal Pharmaceuticals
Oct 2, 2024
Maintains: Buy
Price Target: $10 → $12
Current: $11.64
Upside: +3.09%